CX2101A

· Heronova Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CX2101A, covering 2025-03-14 to 2025-03-14. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability Study of CX2101A for the Treatment of COVID-19 [Phase 1]